• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD
United Arab Emirates Pharmaceuticals and Healthcare Report Q1 2010 - Product Image

United Arab Emirates Pharmaceuticals and Healthcare Report Q1 2010

  • ID: 1197333
  • December 2009
  • Region: United Arab Emirates
  • 96 Pages
  • Business Monitor International

FEATURED COMPANIES

  • Abbott Laboratories
  • GlaxoSmithKline
  • Globalpharma
  • Johnson & Johnson (J&J)
  • Merck & Co
  • NeoPharma
  • MORE

United Arab Emirates Pharmaceuticals and Healthcare Report provides industry professionals and strategists, corporate analysts, pharmaceutical associations, government departments and regulatory bodies with independent forecasts and competitive intelligence on the United Arab Emirates' pharmaceuticals and healthcare industry.

In November 2009 the UAE government announced that an independent federal authority will be established to regulate the quality and safety of food and drugs entering the country. BMI believes that the successful implementation of this body – essentially a UAE version of the US Food and Drug Administration (FDA) – will be attractive to multinational drugmakers operating in the country.

We expect the total drug market to increase in value from US$1.31bn in 2008 to US$1.5bn by 2009. Thereafter, we expect the drug market to reach US$2.65bn by 2014, representing a compound annual growth rate (CAGR) of 21% in US dollar terms. Our extended 10-year forecast indicates that the market will reach US$3.4bn by 2019, showing a slow CAGR of 5.2% from 2014 onwards. We believe that as the second largest pharmaceutical market in the Gulf Co-operation Council READ MORE >

Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Abbott Laboratories
  • GlaxoSmithKline
  • Globalpharma
  • Johnson & Johnson (J&J)
  • Merck & Co
  • NeoPharma
  • MORE

EXECUTIVE SUMMARY

SWOT ANALYSIS
United Arab Emirates Pharmaceuticals And Healthcare Industry SWOT
United Arab Emirates Political SWOT
United Arab Emirates Economic SWOT
United Arab Emirates Business Environment SWOT

PHARMACEUTICAL BUSINESS ENVIRONMENT RATINGS
Table: Middle East And Africa Pharmaceutical Business Environment Ratings for Q110
Limits To Potential Returns
Risks To Realisation Of Returns

UAE - MARKET SUMMARY

REGULATORY ENVIRONMENT
Recent Regulatory Developments
Pharmaceutical Advertising
Intellectual Property Regime
Counterfeit Medicines
Pricing And Reimbursement Regime
Recent Pricing And Reimbursement Developments
Regional Harmonisation
Free Trade Agreements

INDUSTRY TRENDS AND DEVELOPMENTS
Epidemiology
Healthcare Sector
Healthcare Sector Reforms
Recent Healthcare Sector Developments
Hospital Sector Developments
Health Insurance
Recent Health Insurance Industry Developments
Health Tourism
Domestic Pharmaceutical Sector
Foreign Companies
Company Developments
Pharmaceutical Distribution and Retail
Recent Developments in Pharmaceutical Distribution and Retail
Research and Development
DuBiotech
Medical Devices
Recent Developments In The Medical Devices Market

INDUSTRY FORECAST SCENARIO
Overall Market Forecast
Key Growth Factors – Industry
Macroeconomic Scenario
United Arab Emirates – Economic Activity, 2007-2014
Prescription Drug Market Forecasts
Patented Drug Market Forecasts
Generic Drug Market Forecast
OTC Drug Market Forecast
Pharmaceutical Trade Forecast
Pharmaceutical Trade Forecast
Medical Devices
Other Healthcare Forecasts
Key Risks To BMI’s Forecast Scenario

COMPETITIVE LANDSCAPE

COMPANY PROFILES
Leading Foreign Companies
GlaxoSmithKline
Pfizer
Novartis
Johnson & Johnson (J&J)
Sanofi-Aventis
Abbott Laboratories
Merck & Co
Indigenous Manufacturers
Gulf Pharmaceutical Industries (Julphar)
Globalpharma
Modern Pharmaceutical Company (MPC)
NeoPharma

COUNTRY SNAPSHOT: UAE DEMOGRAPHIC DATA
Section 1: Population
Table: Demographic Indicators, 2005-2030
Table: Rural/Urban Breakdown, 2005-2030
Section 2: Education And Healthcare
Table: Education, 2002-2005
Table: Vital Statistics, 2005-2030
Section 3: Labour Market And Spending Power
Table: Employment Indicators, 2000-2004
Table: Consumer Expenditure, 2000-2012 (US$)

BMI METHODOLOGY
How We Generate Our Pharmaceutical Industry Forecasts
Pharmaceutical Business Environment Ratings Methodology
Ratings Overview
Table: Pharmaceutical Business Environment Indicators
Weighting
Table: Weighting Of Components
Sources

DATA TABLES

Note: Product cover images may vary from those shown

- GlaxoSmithKline
- Pfizer
- Novartis
- Johnson & Johnson (J&J)
- Sanofi-Aventis
- Abbott Laboratories
- Merck & Co
- Gulf Pharmaceutical Industries (Julphar)
- Globalpharma
- Modern Pharmaceutical Company (MPC)
- NeoPharma

Note: Product cover images may vary from those shown
Note: Product cover images may vary from those shown

RELATED PRODUCTS

Our Clients

Our clients' logos